MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

United Therapeutics Company Profile (NASDAQ:UTHR)

Consensus Ratings for United Therapeutics (NASDAQ:UTHR) (?)
Ratings Breakdown: 1 Sell Rating(s), 6 Hold Rating(s), 6 Buy Rating(s)
Consensus Rating:Hold (Score: 2.38)
Consensus Price Target: $163.50 (55.42% upside)

Analysts' Ratings History for United Therapeutics (NASDAQ:UTHR)
Show:
DateFirmActionRatingPrice TargetActions
4/29/2016Ladenburg ThalmannDowngradeBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/28/2016Cowen and CompanyReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/25/2016WedbushReiterated RatingOutperform$229.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/16/2016Leerink SwannReiterated RatingMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/11/2016RBC CapitalReiterated RatingSector Perform$150.00 -> $122.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/28/2016HC WainwrightReiterated RatingBuy$175.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/26/2016BarclaysLower Price TargetEqual Weight$155.00 -> $145.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/10/2016Standpoint ResearchUpgradeHold -> Buy$148.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/31/2015ArgusLower Price TargetBuy$205.00 -> $200.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/20/2015Goldman SachsLower Price TargetSell$98.00 -> $95.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/18/2015BTIG ResearchUpgradeNeutral -> Buy$225.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2015JPMorgan Chase & Co.Reiterated RatingNeutral$147.00 -> $158.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2015Jefferies GroupReiterated RatingHold$143.00 -> $155.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/11/2014Credit SuisseDowngradeNeutral -> Underperform$100.00 -> $120.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/2/2014GuggenheimBoost Price Target$101.00 -> $105.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 4/30/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha